Elixir Medical
Sunnyvale-based Elixir Medical Corp. develops advanced medical devices and pharmaceuticals for effective cardiovascular treatment.
Founded
2004Sunnyvale-based Elixir Medical Corp. develops advanced medical devices and pharmaceuticals for effective cardiovascular treatment.
Elixir Medical Corporation, headquartered in Sunnyvale, California, is dedicated to developing advanced medical devices and pharmaceuticals aimed at providing effective cardiovascular treatments. The company's core products include next-generation drug-eluting stent systems designed to optimize localized drug delivery, enhancing the safety and efficacy of treatments for cardiovascular patients. Their market focus is on improving outcomes for individuals suffering from coronary artery disease.
Elixir Medical has achieved significant milestones, including the FDA Breakthrough Device Designation for its DynamX Sirolimus-Eluting Coronary Bioadaptor System. This recognition underscores the innovative nature of their technology and its potential to offer superior treatment options for symptomatic ischemic heart disease. The bioadaptor system aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression, marking a notable impact in the field of cardiovascular health.
Companies similar to Elixir Medical include eLum Technologies, Endologix, VytronUS and Svelte Medical Systems.
Elixir Medical was founded in 2004.
Elixir Medical's headquarters is located in Sunnyvale, CA, US.
Elixir Medical's most recent funding round was for $5.3M (USD) in March 2005.
As of Mar 18, 2005, Elixir Medical has disclosed funding of $5.3M (USD). Undisclosed round amounts are excluded.
Elixir Medical has 75 employees as of Feb 4, 2024.
